Acipimox
Acipimox is a nicotinic acid analog used as a hypolipidemic agent in research. It is particularly studied for managing hyperlipidemia in type 2 diabetic models, with applications in investigating lipid metabolism through both in vitro and in vivo experimental systems.
Product Specifications
CAS Number
51037-30-0
Product Name Alternative
Olbemox, nicotinic, inhibit, K9321, K-9321, K 9321, lipolysis, Inhibitor, derivative, diabetes, antilipolytic, analogue, autonomic, Acipimox, acid, triglycerides production, tone
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
>98%
Bioactivity
GPR109A agonist
Form
Powder
Solubility
DMSO:50 mg/mL (324.42 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (12.98 mM) ; H2O:15.4 mg/mL (99.92 mM)
Smiles
C (O) (=O) C=1C=N (=O) C (C) =CN1
Molecular Formula
C6H6N2O3
Molecular Weight
154.12
Storage Conditions
RT
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15268983 1 Vial
Lentiviral mouse Mnat1 shRNA (UAS) - Lentiviral mouse Mnat1 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details